VRDN Competitors & Alternatives
Compare Viridian Therapeutics Inc with similar stocks in the same industry
Biotechnology
VRDN
Main Stock$24.29
Tradestie Score
37
Market Cap
$1.74B
Revenue Growth
2.8%
Analyst Upside
+50.8%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.65
|
$3.09B | - | 42 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$33.89
|
$3.08B | - | 54 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$60.77
|
$3.02B | - | 58 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$79.81
|
$3.01B | - | 39 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$25.83
|
$2.89B | - | 57 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$44.37
|
$2.85B | - | 36 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
More VRDN Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry